SARAH LOZANO: Open Payments
NPI 1629364435 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,526 in 84 payments from 11 companies in 2025. Trend: 2023 $1,231 · 2024 $1,071 · 2025 $1,526
Food & beverage: $1,526
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $281 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $242 |
| PFIZER INC. | 10 | $222 |
| Janssen Biotech, Inc. | 11 | $165 |
| Gilead Sciences, Inc. | 9 | $143 |
| Ardelyx, Inc. | 5 | $130 |
| Madrigal Pharmaceuticals | 4 | $112 |
| Phathom Pharmaceuticals, Inc. | 7 | $97 |
| Regeneron Healthcare Solutions, Inc. | 3 | $66 |
| Ipsen Biopharmaceuticals, Inc | 3 | $50 |
Products named: ENTYVIO, VELSIPITY, RINVOQ, TREMFYA, IBSRELA, REZDIFFRA, VOQUEZNA, MAVYRET.
Industry payments across TX — which companies pay providers there.
